Home > News > BioTrove, Inc. Secures $10.9 Million
January 29th, 2004
BioTrove, Inc. Secures $10.9 Million
BioTrove, Inc. today announced that the company has successfully raised $10.9 million in venture capital funding. The investors supporting the financing include Catalyst Health and Technology Partners, CB Health Ventures, Zero Stage Capital and BioFrontier Partners. The funds will be used to continue the development and commercialization of the Company's micro- and nano-scale products and services, the Living Chip(TM) and Momentum(TM) Assay Development and Screening.
Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 July 23rd, 2014
Nanometrics Announces Upcoming Investor Events July 22nd, 2014
Harris & Harris Group Invests in UberSeq, Inc. July 16th, 2014
Harris & Harris Group Portfolio Company D-Wave Systems Closes a $28.4 Million Financing July 14th, 2014